Swanand Hardikar

1.3k total citations
17 papers, 753 citations indexed

About

Swanand Hardikar is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Swanand Hardikar has authored 17 papers receiving a total of 753 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 3 papers in Hematology and 3 papers in Genetics. Recurrent topics in Swanand Hardikar's work include Epigenetics and DNA Methylation (15 papers), RNA modifications and cancer (6 papers) and Cancer-related gene regulation (6 papers). Swanand Hardikar is often cited by papers focused on Epigenetics and DNA Methylation (15 papers), RNA modifications and cancer (6 papers) and Cancer-related gene regulation (6 papers). Swanand Hardikar collaborates with scholars based in United States, China and Canada. Swanand Hardikar's co-authors include Taiping Chen, Hongbo Zhao, Margaret A. Goodell, Anup K. Singh, Nicolás Veland, Jiameng Dan, Soo Jin Kim, Jianjun Shen, Yue Lu and Kevin Lin and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Swanand Hardikar

17 papers receiving 741 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Swanand Hardikar United States 12 644 140 119 72 60 17 753
David J. Young United States 16 556 0.9× 226 1.6× 118 1.0× 34 0.5× 72 1.2× 35 835
Ali Aghajanirefah Netherlands 7 221 0.3× 109 0.8× 56 0.5× 46 0.6× 111 1.9× 11 366
Babu Rao Vundinti India 13 219 0.3× 180 1.3× 53 0.4× 74 1.0× 106 1.8× 50 406
Richard A. Voit United States 11 542 0.8× 179 1.3× 200 1.7× 42 0.6× 276 4.6× 17 783
Nicolas Bonadies Switzerland 14 423 0.7× 264 1.9× 64 0.5× 47 0.7× 121 2.0× 39 723
Rajan K. Mannari United States 3 693 1.1× 384 2.7× 71 0.6× 66 0.9× 66 1.1× 3 847
Jon Burdach Australia 11 455 0.7× 79 0.6× 81 0.7× 122 1.7× 197 3.3× 14 576
Yakun Pang China 11 253 0.4× 173 1.2× 46 0.4× 90 1.3× 50 0.8× 22 458
Mauri Keinänen Finland 11 216 0.3× 255 1.8× 91 0.8× 54 0.8× 80 1.3× 14 466
Victoria Bryant United States 8 113 0.2× 153 1.1× 100 0.8× 31 0.4× 54 0.9× 14 348

Countries citing papers authored by Swanand Hardikar

Since Specialization
Citations

This map shows the geographic impact of Swanand Hardikar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Swanand Hardikar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Swanand Hardikar more than expected).

Fields of papers citing papers by Swanand Hardikar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Swanand Hardikar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Swanand Hardikar. The network helps show where Swanand Hardikar may publish in the future.

Co-authorship network of co-authors of Swanand Hardikar

This figure shows the co-authorship network connecting the top 25 collaborators of Swanand Hardikar. A scholar is included among the top collaborators of Swanand Hardikar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Swanand Hardikar. Swanand Hardikar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
Chen, Qin, Swanand Hardikar, Kimie Kondo, et al.. (2025). GSK-3484862, a DNMT1 degrader, promotes DNMT3B expression in lung cancer cells. NAR Cancer. 7(2). zcaf018–zcaf018. 1 indexed citations
3.
Hardikar, Swanand, Ren Ren, Zhengzhou Ying, et al.. (2024). The ICF syndrome protein CDCA7 harbors a unique DNA binding domain that recognizes a CpG dyad in the context of a non-B DNA. Science Advances. 10(34). eadr0036–eadr0036. 11 indexed citations
4.
Shen, Lei, Xiaokuang Ma, Yuanyuan Wang, et al.. (2024). Loss-of-function mutation in PRMT9 causes abnormal synapse development by dysregulation of RNA alternative splicing. Nature Communications. 15(1). 2809–2809. 5 indexed citations
5.
Ying, Zhengzhou, Swanand Hardikar, Joshua B. Plummer, et al.. (2023). Enhanced CD19 activity in B cells contributes to immunodeficiency in mice deficient in the ICF syndrome gene Zbtb24. Cellular and Molecular Immunology. 20(12). 1487–1498. 8 indexed citations
6.
Villarreal, Oscar D., Swanand Hardikar, Zhenbao Yu, et al.. (2022). PRMT7 ablation stimulates anti-tumor immunity and sensitizes melanoma to immune checkpoint blockade. Cell Reports. 38(13). 110582–110582. 39 indexed citations
7.
DiNardo, Courtney D., Hannah C. Beird, Marcos R. Estecio, et al.. (2020). Germline DNMT3A mutation in familial acute myeloid leukaemia. Epigenetics. 16(5). 567–576. 7 indexed citations
8.
Zeng, Yang, Ren Ren, Gundeep Kaur, et al.. (2020). The inactive Dnmt3b3 isoform preferentially enhances Dnmt3b-mediated DNA methylation. Genes & Development. 34(21-22). 1546–1558. 50 indexed citations
9.
Ren, Ren, Swanand Hardikar, J.R. Horton, et al.. (2019). Structural basis of specific DNA binding by the transcription factor ZBTB24. Nucleic Acids Research. 47(16). 8388–8398. 31 indexed citations
10.
Hamidi, Tewfik, Anup K. Singh, Nicolás Veland, et al.. (2018). Identification of Rpl29 as a major substrate of the lysine methyltransferase Set7/9. Journal of Biological Chemistry. 293(33). 12770–12780. 27 indexed citations
11.
Gu, Tianpeng, Xueqiu Lin, Sean M. Cullen, et al.. (2018). DNMT3A and TET1 cooperate to regulate promoter epigenetic landscapes in mouse embryonic stem cells. Genome biology. 19(1). 88–88. 105 indexed citations
12.
Veland, Nicolás, Yue Lu, Swanand Hardikar, et al.. (2018). DNMT3L facilitates DNA methylation partly by maintaining DNMT3A stability in mouse embryonic stem cells. Nucleic Acids Research. 47(1). 152–167. 101 indexed citations
13.
Veland, Nicolás, Swanand Hardikar, Yi Zhong, et al.. (2017). The Arginine Methyltransferase PRMT6 Regulates DNA Methylation and Contributes to Global DNA Hypomethylation in Cancer. Cell Reports. 21(12). 3390–3397. 57 indexed citations
14.
Dan, Jiameng, Philippe Rousseau, Swanand Hardikar, et al.. (2017). Zscan4 Inhibits Maintenance DNA Methylation to Facilitate Telomere Elongation in Mouse Embryonic Stem Cells. Cell Reports. 20(8). 1936–1949. 79 indexed citations
15.
Kim, Jeesun, Hongbo Zhao, Jiameng Dan, et al.. (2016). Maternal Setdb1 Is Required for Meiotic Progression and Preimplantation Development in Mouse. PLoS Genetics. 12(4). e1005970–e1005970. 69 indexed citations
16.
Kim, Soo Jin, Hongbo Zhao, Swanand Hardikar, et al.. (2013). A DNMT3A mutation common in AML exhibits dominant-negative effects in murine ES cells. Blood. 122(25). 4086–4089. 130 indexed citations
17.
Taylor, K M, Moshe Talpaz, H. Kantarjian, et al.. (1989). Myeloproliferative disorders: usefulness of X-linked probes in diagnosis.. PubMed. 3(6). 419–22. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026